Allogeneic Stem Cell Transplant

An allogeneic stem cell transplant replaces damaged or diseased blood-forming cells with healthy stem cells from a donor.

The donor cells travel through the bloodstream to the bone marrow, where they can begin making blood cells. Unlike a transplant using your own collected cells, this treatment introduces another person’s immune cells, which can act against disease but also require close monitoring.

Assessment includes blood tests, scans or heart and lung checks, a review of infections and medicines, and donor matching. Conditioning treatment is given before the donor cells. It may include chemotherapy, radiation or both, selected for the condition and the person’s fitness.

The stem-cell infusion itself is given into a vein, much like a blood transfusion. Afterward, you stay under close clinical supervision while the new cells settle and blood counts recover.

Conditioning can cause tiredness, nausea, mouth soreness, diarrhoea, appetite loss and hair loss. Low blood counts can increase infection and bleeding risk. Immune-suppressing medicines, transfusions and nutritional support may be needed during recovery.

Urgent review is needed for fever, chills, breathing difficulty, chest pain, severe diarrhoea, persistent vomiting, new rash, yellowing of the eyes or skin, unusual bleeding, confusion or a sudden reduction in urine. These signs can have different causes and should not wait for a routine appointment.

A transplant is considered when its potential to control the underlying disease or restore marrow function may outweigh its risks. The outlook depends on the condition, disease status, donor match, conditioning plan, age, general health and complications during recovery.

The transplant team discusses the personal goals of treatment and the uncertainty involved before proceeding. Follow-up remains essential because recovery and immune rebuilding continue after discharge.

This is a complex treatment delivered through a specialist transplant service. Protective measures against infection, regular blood tests and medicines to limit immune reactions are central parts of care. Family or friends may be asked to help with transport, meals and keeping the home environment clean during recovery.

A donor transplant may be considered for selected blood cancers, marrow disorders or immune-related marrow failure when other treatment plans are not suitable or are unlikely to provide lasting control. Conditions that may be assessed include acute leukaemias, myelodysplastic syndromes, myelofibrosis and aplastic anaemia.

The process starts with transplant assessment and donor selection. Conditioning then takes place before the infusion. During the period of low blood counts, the team monitors tests and symptoms closely, treats complications and adjusts supportive medicines. After discharge, frequent visits continue until recovery is more stable.

Recovery has several stages: early healing while blood counts are low, transition home with close outpatient care, and longer-term rebuilding of strength and immunity. Fatigue can persist, and returning to work, school or travel should be discussed with the transplant team. Vaccination planning is individual after transplant.

Risks include severe infection, bleeding, organ effects from conditioning, delayed recovery of blood counts and graft-versus-host disease. Graft-versus-host disease occurs when donor immune cells react against the recipient’s tissues; it can affect the skin, gut, liver and other organs. Preventive medicines and early reporting of changes are important.

Alternatives depend on the diagnosis and may include medicines, lower-intensity treatment, supportive transfusions, an autologous stem cell transplant or cellular therapy. A specialist explains whether an alternative is appropriate for the disease stage, previous treatments and available donor options.

Seek care through a specialist haematology and transplant service that can coordinate donor collection, inpatient care, laboratory monitoring, infection management and long-term follow-up. At the consultation, ask how urgent concerns are handled outside clinic hours and which family member can receive updates with your permission.